Pipeline

Overview

Project Indication Region Basic research Pre-clinical PhaseⅠ PhaseⅡ PhaseⅢ Launch

ITK-1

  1. Cancer peptide vaccine
  2. Licensed to FUJIFILM Corp
Prostate cancerJP
No statistical differences in primary endpoint to placebo

GRN-1201

  1. Cancer peptide vaccine
  2. For use in combination with an immune checkpoint inhibitor (for non-small cell lung cancer)
Non-small cell lung cancerUS
MelanomaUS

GRN-1301

  1. Drug resistant tumor-derived neoantigen
Non-small cell lung cancerTBD

iPS-NKT

  1. Induced pluripotent stem cell (iPSC) derived rejuvenated NKT cell therapy
  2. In-license Option
Head and neck cancers JP
close